Literature DB >> 11479264

Manipulation of the renin-angiotensin system.

M M Givertz1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11479264     DOI: 10.1161/hc3001.094733

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  24 in total

Review 1.  Quinapril: a further update of its pharmacology and therapeutic use in cardiovascular disorders.

Authors:  Christine R Culy; Blair Jarvis
Journal:  Drugs       Date:  2002       Impact factor: 9.546

2.  Response to Sexton: Inhibiting the renin-angiotensin-aldosterone system in patients with heart failure and renal dysfunction: common sense or nonsense?

Authors:  Javed Butler; Michael M Givertz
Journal:  Circ Heart Fail       Date:  2014-05       Impact factor: 8.790

Review 3.  Role of the ACE2/Angiotensin 1-7 Axis of the Renin-Angiotensin System in Heart Failure.

Authors:  Vaibhav B Patel; Jiu-Chang Zhong; Maria B Grant; Gavin Y Oudit
Journal:  Circ Res       Date:  2016-04-15       Impact factor: 17.367

4.  Racial Differences in Diuretic Efficiency, Plasma Renin, and Rehospitalization in Subjects With Acute Heart Failure.

Authors:  Alanna A Morris; Aditi Nayak; Yi-An Ko; Melroy D'Souza; G Michael Felker; Margaret M Redfield; W H Wilson Tang; Jeffrey M Testani; Javed Butler
Journal:  Circ Heart Fail       Date:  2020-07-08       Impact factor: 8.790

Review 5.  Fixed combination trandolapril/verapamil sustained-release: a review of its use in essential hypertension.

Authors:  Richard B R Muijsers; Monique P Curran; Caroline M Perry
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 6.  Left atrial remodelling contributes to the progression of asymptomatic left ventricular systolic dysfunction to chronic symptomatic heart failure.

Authors:  George Karayannis; George Kitsios; Haralambos Kotidis; Filippos Triposkiadis
Journal:  Heart Fail Rev       Date:  2007-04-21       Impact factor: 4.214

7.  Reduction of Cardiovascular Risk through Angiotensin II Type 1 Receptor Antagonism : Focus on Olmesartan Medoxomil.

Authors:  Enrico Agabiti Rosei
Journal:  High Blood Press Cardiovasc Prev       Date:  2013-01-22

Review 8.  Comparison of angiotensin II type 1 receptor antagonists in the treatment of essential hypertension.

Authors:  David H G Smith
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 9.  The past, present and future of renin-angiotensin aldosterone system inhibition.

Authors:  Robert J Mentz; George L Bakris; Bernard Waeber; John J V McMurray; Mihai Gheorghiade; Luis M Ruilope; Aldo P Maggioni; Karl Swedberg; Ileana L Piña; Mona Fiuzat; Christopher M O'Connor; Faiez Zannad; Bertram Pitt
Journal:  Int J Cardiol       Date:  2012-10-31       Impact factor: 4.164

10.  Sex-Specific Changes in Renal Angiotensin-Converting Enzyme and Angiotensin-Converting Enzyme 2 Gene Expression and Enzyme Activity at Birth and Over the First Year of Life.

Authors:  Kai Chen; Jianli Bi; Yixin Su; Mark C Chappell; James C Rose
Journal:  Reprod Sci       Date:  2015-08-04       Impact factor: 3.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.